- Home
- UP vs AVDL Comparison
UP vs AVDL Comparison
Compare UP & AVDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UP
- AVDL
- Stock Information
- Founded
- UP 2013
- AVDL 2015
- Country
- UP United States
- AVDL Ireland
- Employees
- UP N/A
- AVDL N/A
- Industry
- UP Aerospace
- AVDL Biotechnology: Pharmaceutical Preparations
- Sector
- UP Consumer Discretionary
- AVDL Health Care
- Exchange
- UP Nasdaq
- AVDL Nasdaq
- Market Cap
- UP 1.2B
- AVDL 786.3M
- IPO Year
- UP N/A
- AVDL 1996
- Fundamental
- Price
- UP $1.50
- AVDL $8.38
- Analyst Decision
- UP
- AVDL Strong Buy
- Analyst Count
- UP 0
- AVDL 6
- Target Price
- UP N/A
- AVDL $20.00
- AVG Volume (30 Days)
- UP 927.1K
- AVDL 1.8M
- Earning Date
- UP 03-06-2025
- AVDL 03-03-2025
- Dividend Yield
- UP N/A
- AVDL N/A
- EPS Growth
- UP N/A
- AVDL N/A
- EPS
- UP N/A
- AVDL N/A
- Revenue
- UP $833,669,000.00
- AVDL $138,160,000.00
- Revenue This Year
- UP $38.03
- AVDL $515.63
- Revenue Next Year
- UP $25.66
- AVDL $49.32
- P/E Ratio
- UP N/A
- AVDL N/A
- Revenue Growth
- UP N/A
- AVDL 1523.50
- 52 Week Low
- UP $1.45
- AVDL $7.39
- 52 Week High
- UP $4.59
- AVDL $19.09
- Technical
- Relative Strength Index (RSI)
- UP 32.58
- AVDL 44.82
- Support Level
- UP $1.45
- AVDL $7.40
- Resistance Level
- UP $1.65
- AVDL $8.01
- Average True Range (ATR)
- UP 0.07
- AVDL 0.33
- MACD
- UP 0.00
- AVDL 0.14
- Stochastic Oscillator
- UP 19.23
- AVDL 97.51
About UP Wheels Up Experience Inc.
Wheels Up Experience Inc is a provider of on-demand private aviation in the United States. It is pioneering data and technology-driven solutions that connect consumers to safety-vetted and verified private aircraft. It connects private flyers to aircraft, and one another, through an open platform that enables life's most important experiences. Its offering is delivered through a mix of programmatic and charter options that strategically utilize its owned and leased aircraft fleet and an "asset-light" charter model to deliver a greater range of global travel alternatives. The company operates in a single operating and reportable segment, private aviation services. Geographically the company generates the majority of its revenue from the United States.
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.